Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing
Open Access
- 27 January 2011
- journal article
- research article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 18 (1), 67-76
- https://doi.org/10.1016/j.chembiol.2010.11.009
Abstract
No abstract availableThis publication has 54 references indexed in Scilit:
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- Genome-wide RNAi screen identifies human host factors crucial for influenza virus replicationNature, 2010
- Cdc2-like Kinase 2 Is an Insulin-Regulated Suppressor of Hepatic GluconeogenesisCell Metabolism, 2010
- Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)Bioorganic & Medicinal Chemistry Letters, 2009
- The pathobiology of splicingThe Journal of Pathology, 2009
- Measuring and interpreting the selectivity of protein kinase inhibitorsJournal of Chemical Biology, 2009
- Kinase Domain Insertions Define Distinct Roles of CLK Kinases in SR Protein PhosphorylationStructure, 2009
- The Spliceosome: Design Principles of a Dynamic RNP MachineCell, 2009
- VEGF-A splicing: the key to anti-angiogenic therapeutics?Nature Reviews Cancer, 2008
- A serine kinase regulates intracellular localization of splicing factors in the cell cycleNature, 1994